Cosmos Pharm stock heads toward October 13 results

Published on 10/07/2026 at 01:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cosmos Pharm stock heads toward October 13 results after fiscal 2026 revenue reached JPY 1.099 trillion, up 8.72 percent. Analysts set a JPY 7,620 average target.

Cosmos Pharm, JP3298400007, Illustration mit AI erstellt.

Cosmos Pharm stock was last at JPY 6,314 on the Tokyo Stock Exchange on October 6, 2026 at 3:30 p.m. JST, down 0.22 percent on the session. The next first-quarter results date is October 13, 2026, according to Kabuyoho Pro.

Revenue reaches JPY 1.099 trillion

Cosmos Pharmaceutical Corporation reported fiscal 2026 revenue of JPY 1.099 trillion for the year ended May 31, 2026, compared with JPY 1.011 trillion in fiscal 2025. That represents growth of 8.72 percent, while operating profit rose from JPY 40.404 billion to JPY 42.353 billion.

6ix lists the fiscal 2026 results as Japanese GAAP figures published on July 13, 2026. Net income attributable to shareholders reached JPY 32.046 billion, up from JPY 30.978 billion in fiscal 2025, giving investors a second growth comparison before the October results date.

Analysts see JPY 7,620 target

The analyst picture is constructive but not uniform. According to Investing.com, 10 analysts produce a consensus Buy rating, with 5 Buy ratings, 5 Holds and 0 Sells.

The same 12-month consensus carries an average target of JPY 7,620, with a high of JPY 9,600 and a low of JPY 6,700. Against the October 6 price of JPY 6,314, the average target lies 20.7 percent above the stock. A separate analyst action reported by Yahoo Finance Japan kept the rating at Neutral on September 7, 2026, while raising the target from JPY 6,510 to JPY 6,700.

Stock remains below yearly high

The October 6 quote sits between the current 52-week low of JPY 5,615 and high of JPY 8,590. The JPY 500.4 billion market capitalization and 362,900-share trading volume give the upcoming results a sizeable listed-equity base.

Cosmos Pharmaceutical operates a Japanese drugstore business spanning medicines, daily necessities and food. Its fiscal 2026 operating margin was 3.9 percent, compared with 4.0 percent in fiscal 2025, so revenue expansion has not fully translated into wider operating profitability.

Cosmos Pharm stock awaits October 13

Cosmos Pharm stock was last at JPY 6,314 on the Tokyo Stock Exchange on October 6, 2026 at 3:30 p.m. JST. The October 13 first-quarter report is the next dated checkpoint for testing whether the company's sales growth can offset its slightly narrower operating margin.